DKSH and Hofseth BioCare enter distribution agreement

Published: 10-Dec-2020

The partnership will jointly managed by DKSH's Food & Beverage and Pharmaceutical Business Lines and will cover Hofseth’s ProGo, CollaGo, CalGo and OmeGo products

DKSH’s Business Unit Performance Materials and Hofseth BioCare ASA have entered into an exclusive distribution agreement for DKSH to provide regulatory services, distribution, marketing and sales to Hofseth for its ingredients and products across Asia.

Under the agreement, DKSH will provide exclusive services across ten markets in Asia. Hofseth's product range is non-GMO and antibiotic-free, and the only by-product of the manufacturing process is steam, it says.

DKSH will also have the right to sell private labelled finished products to its customer landscape across Asia on a non-exclusive basis.

Roger Hofseth, CEO of HBC said: “We are very happy to partner with DKSH, who has unmatched coverage across Asia Pacific and in the life sciences industry. We focus on innovating and manufacturing high-quality ingredients and products and in turn outsource regulatory services, distribution, sales and marketing to DKSH across Asia.”

“The new partnership with HBC is a great match. DKSH gets access to the innovative, sustainable and science-based product range of Hofseth BioCare and they in turn access our established customer base, our network of innovation centers and our in-depth industry knowledge. We are looking forward to a successful partnership with HBC,” commented Thomas Sul, Co-Head of Business Unit Performance Materials and member of the DKSH Executive Committee.

You may also like